Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Experimental & Translational Stroke Medicine 7(1):2 doi:10.1186/s13231-014-0014-y
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Gießen
- (wer)
-
Universitätsbibliothek
- (wann)
-
2016
- Beteiligte Personen und Organisationen
-
Tomkins, Amelia J.
Schleicher, Nadine
Murtha, Lucy
Kaps, Manfred
Levi, Christopher R.
Nedelmann, Max
Spratt, Neil J.
- URN
-
urn:nbn:de:hebis:26-opus-119630
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tomkins, Amelia J.
- Schleicher, Nadine
- Murtha, Lucy
- Kaps, Manfred
- Levi, Christopher R.
- Nedelmann, Max
- Spratt, Neil J.
- Universitätsbibliothek
Entstanden
- 2016
Ähnliche Objekte (12)
Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke
Development of an in vitro model to study clot lysis activity of thrombolytic drugs
A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
Real-Time Imaging of Platelet-Initiated Plasma Clot Formation and Lysis Unveils Distinct Impacts of Anticoagulants
Clot composition of embolic strokes of undetermined source: a feasibility study
Material strengths of shear-induced platelet aggregation clots and coagulation clots
Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke
Clot lysis time and thrombin generation in patients undergoing transcatheter aortic valve implantation
Addition of a sequence from α2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis
Plasma clot formation and clot lysis to compare effects of different anticoagulation treatments on hemostasis in patients with atrial fibrillation
Thrombectomy vs. Systemic Thrombolysis in Acute Embolic Stroke with High Clot Burden: A Retrospective Analysis
Lysis
Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke
Development of an in vitro model to study clot lysis activity of thrombolytic drugs
A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
Real-Time Imaging of Platelet-Initiated Plasma Clot Formation and Lysis Unveils Distinct Impacts of Anticoagulants
Clot composition of embolic strokes of undetermined source: a feasibility study
Material strengths of shear-induced platelet aggregation clots and coagulation clots
Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke
Clot lysis time and thrombin generation in patients undergoing transcatheter aortic valve implantation
Addition of a sequence from α2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis
Plasma clot formation and clot lysis to compare effects of different anticoagulation treatments on hemostasis in patients with atrial fibrillation
Thrombectomy vs. Systemic Thrombolysis in Acute Embolic Stroke with High Clot Burden: A Retrospective Analysis
Lysis
Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke
Development of an in vitro model to study clot lysis activity of thrombolytic drugs
A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
Real-Time Imaging of Platelet-Initiated Plasma Clot Formation and Lysis Unveils Distinct Impacts of Anticoagulants
Clot composition of embolic strokes of undetermined source: a feasibility study
Material strengths of shear-induced platelet aggregation clots and coagulation clots
Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke
Clot lysis time and thrombin generation in patients undergoing transcatheter aortic valve implantation
Addition of a sequence from α2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis
Plasma clot formation and clot lysis to compare effects of different anticoagulation treatments on hemostasis in patients with atrial fibrillation
Thrombectomy vs. Systemic Thrombolysis in Acute Embolic Stroke with High Clot Burden: A Retrospective Analysis